ArticleGenome medicine2018
Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience.
Abstract readPublished Erratum
In one paragraph
Article in Genome medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impaired dynamic interaction of axonal endoplasmic reticulum and ribosomes contributes to defective stimulus-response in spinal muscular atrophy.Translational neurodegeneration · 2022Article
- Axonal Endoplasmic Reticulum Dynamics and Its Roles in Neurodegeneration.Frontiers in neuroscience · 2020Review
Corrections and comments
- Erratum for
Authors and funding
32 authors.
Perry G RidgeDepartment of Biology, Brigham Young University, Provo, UT, 84602, USA.
Celeste M KarchWashington University School of Medicine, St. Louis, MO, 63110, USA.
Simon HsuWashington University School of Medicine, St. Louis, MO, 63110, USA.
Ivan AranoDepartment of Biology, Brigham Young University, Provo, UT, 84602, USA.
Craig C TeerlinkDivision of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, 84132, USA.
Mark T W EbbertDepartment of Biology, Brigham Young University, Provo, UT, 84602, USA.
Josue D Gonzalez MurciaDepartment of Biology, Brigham Young University, Provo, UT, 84602, USA.
James M FarnhamDivision of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, 84132, USA.
Anna R DamatoWashington University School of Medicine, St. Louis, MO, 63110, USA.
Mariet AllenDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Xue WangDepartment of Health Sciences Research, Mayo Clinic, Jacksonville, FL, 32224, USA.
Oscar HarariWashington University School of Medicine, St. Louis, MO, 63110, USA.
Victoria M FernandezWashington University School of Medicine, St. Louis, MO, 63110, USA.
Rita GuerreiroDepartment of Molecular Neuroscience, Institute of Neurology, University College London, London, UK.
Jose BrasDepartment of Molecular Neuroscience, Institute of Neurology, University College London, London, UK.
John HardyDepartment of Molecular Neuroscience, Institute of Neurology, University College London, London, UK.
Ronald MungerDepartment of Nutrition, Dietetics, and Food Sciences, Utah State University, Logan, UT, 84322, USA.
Maria NortonDepartment of Family Consumer & Human Development, Utah State University, Logan, UT, 84322, USA.
Celeste SassiDepartment of Molecular Neuroscience, Institute of Neurology, University College London, London, UK.
Andrew SingletonNational Institute on Aging, Bethesda, MD, 21224, USA.
Steven G YounkinDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Todd E GoldeCenter for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, University of Florida, Department of Neuroscience, Gainesville, FL, 32610, USA.
Nathan D PriceInstitute for Systems Biology, 401 Terry Avenue N, Seattle, WA, 98109, USA.
Nilüfer Ertekin-TanerDepartments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Carlos CruchagaWashington University School of Medicine, St. Louis, MO, 63110, USA.
Alison M GoateDepartments of Neuroscience, Genetics and Genomic Sciences, and Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Christopher CorcoranDepartment of Mathematics and Statistics, Utah State University, Logan, UT, 84322, USA.
JoAnn TschanzDepartment of Psychology, Utah State University, Logan, UT, 84322, USA.
Lisa A Cannon-AlbrightDivision of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, 84132, USA.
John S K KauweDepartments of Biology and Neuroscience, Brigham Young University, Provo, UT, 84602, USA. kauwe@byu.edu.
Alzheimer’s Disease Neuroimaging Initiative
Funding
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8MWASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1MThe natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI SCHINDLER, SUZANNE ELIZABETH · 2005 to 2025
$49.5MVESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SCHIMMING, CORBETT · 1985 to 2019
$37.9MResearch Education ComponentP30AG066514 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI NIKOLAOS K ROBAKIS · 2020 to 2026
$31.0MIntegrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts.U01AG046139 · NIA · UNIVERSITY OF FLORIDA · PI ERTEKIN-TANER, NILUFER, PETERS, METTE · 2013 to 2022
$24.6MIntegrative translational discovery of vascular risk factors in aging and dementiaRF1AG051504 · NIA · MAYO CLINIC JACKSONVILLE · PI BU, GUOJUN, ERTEKIN-TANER, NILUFER · 2015 to 2019
$9.8MGenetic Analysis Of Alzheimer s DiseaseZIAAG000950 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2009 to 2019
$6.9MGene discovery in PSP by transcriptome, neuropathology and sequence analysisR01NS080820 · NINDS · MAYO CLINIC JACKSONVILLE · PI ERTEKIN-TANER, NILUFER · 2013 to 2017
$1.8MGENETIC DISRUPTION OF TAU METABOLISM IN TAUOPATHIESK01AG046374 · NIA · WASHINGTON UNIVERSITY · PI KARCH, CELESTE MARIE · 2014 to 2018
$568kNIA NIH HHS K01 AG046374NIA NIH HHS P01 AG026276NIA NIH HHS P30 AG066514NIA NIH HHS P50 AG005138NIA NIH HHS P50 AG005681NIA NIH HHS RF1 AG051504NIA NIH HHS U01 AG046139NIA NIH HHS U24 AG021886NINDS NIH HHS R01 NS080820
Abstract
correctionThe original version of this article [1] unfortunately contained a typographical error. The 'Alzheimer's Disease Neuroimaging Initiative' was erroneously included as 'Alzheimer's Disease Neuroimaging Initative' in the author list of the article.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.